Implication of Transforming Growth Factor–β1 in Chagas Disease Myocardiopathy
Citations Over TimeTop 21% of 2002 papers
Abstract
Cardiac dysfunction with progressive fibrosis is a hallmark of Chagas disease. To evaluate the involvement of transforming growth factor (TGF)-beta1 in this disease, TGF-beta1 levels in patients were measured at 3 stages: asymptomatic indeterminate (IND), cardiac with no or slight heart dysfunction (Card 1), and cardiac with moderate or severe heart dysfunction (Card 2). All patients had significantly higher circulating levels of TGF-beta1 than did healthy persons, and 27% of patients in the Card 1 group had higher TGF-beta1 levels than did patients in the IND group. Immunohistochemical analysis of cardiac biopsy specimens showed strong fibronectin staining in the extracellular matrix and staining for phosphorylated Smad 2 (activation of the TGF-beta1 signaling pathway) in cell nuclei. The higher levels of latent TGF-beta1 observed in patients with myocardiopathy, together with intracellular activation of the TGF-beta1 pathway and tissue fibrosis, suggest that TGF-beta1 plays an important role in Chagas disease. TGF-beta1 may represent a new target for preventive and curative treatments of Chagas disease.
Related Papers
- → Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart(2002)148 cited
- → Salvanic acid B inhibits myocardial fibrosis through regulating TGF-β1/Smad signaling pathway(2018)42 cited
- → Forsythiaside B inhibits myocardial fibrosis via down regulating TGF-β1/Smad signaling pathway(2021)18 cited
- → Overexpression of Smad 7 is associated with reduced collagen synthesis in adult cardiac fibroblasts: role of Smad 7 in the development of cardiac fibrosis(2001)
- Study on mechanism of TGF-beta-Smad pathways in myocardial fibrosis(MF) of VMC chronic phase and captopril intervention(2011)